Skip to content
★ Sign in to follow
KB

Kevin Bolin

Executive
QSAM Biosciences, Inc.
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€204k
▼ Sales (0 ops.)
—

Latest filing published 17 May 2017 for QSAM Biosciences, Inc., €190k.

Filing timeline

BuySale
Kevin Bolin

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kevin Bolin: trading record in brief

This profile gathers the share dealings of Kevin Bolin in QSAM Biosciences, Inc. The record holds 2 filings, for trades running from 17 August 2016 to 27 February 2017.

No open-market sale appears; the market trades are 2 purchases worth €204k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2017 to date brings 1 purchase and no sales.

The newest entry dates from 17 May 2017: an open-market purchase of €190k, in QSAM Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kevin Bolin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    DirectorExecutivesQSAM Biosciences, Inc.
    200,000 USD33SEC
    10,000,000 shares@ US$0.0293.0% of flowcommon stockSEC:0001673956-17-000001:0
    Canonical exit: 28 May 2017 (T+90)
  • ▲
    DirectorExecutivesQSAM Biosciences, Inc.
    16,000 USD12SEC
    100,000 shares@ US$0.167.0% of flowcommon stockSEC:0001673956-16-000002:0
    Canonical exit: 15 Nov 2016 (T+90)

2 of 2 declarations